Swelling

RetinalGeniX™ Technologies Inc. Granted a Patent for System And Method For Visualization Of Ocular Anatomy

Retrieved on: 
Thursday, February 22, 2024

PETALUMA, Calif., Feb. 22, 2024 (GLOBE NEWSWIRE) -- RetinalGeniX™ Technologies Inc. (OTCQB:RTGN) (“ RetinalGeniX ” or the “Company”) today announced that it has been granted a patent by the United States Patent and Trademark Office for the Company's System And Method For Visualization Of Ocular Anatomy.

Key Points: 
  • PETALUMA, Calif., Feb. 22, 2024 (GLOBE NEWSWIRE) -- RetinalGeniX™ Technologies Inc. (OTCQB:RTGN) (“ RetinalGeniX ” or the “Company”) today announced that it has been granted a patent by the United States Patent and Trademark Office for the Company's System And Method For Visualization Of Ocular Anatomy.
  • The present invention relates to systems and methods for visualizing eye anatomy for diagnostic and therapeutic purposes.
  • Furthermore, it allows for the detection and analysis of various conditions of the eye, such as, hydration, innervations, inflammation, circulation, nerve conduction, etc.
  • Some of the best-studied ocular conformational diseases include cataracts in the lens and retinitis pigmentosa in the retina.

Herbal medicinal product: Symphyti radixArray, F: Assessment finalised

Retrieved on: 
Tuesday, March 12, 2024

Overview

Key Points: 
  • Overview
    This is a summary of the scientific conclusions reached by the Committee on Herbal Medicinal Products (HMPC) on the medicinal uses of comfrey root.
  • The HMPC conclusions are taken into account by EU Member States when evaluating applications for the licensing of herbal medicines containing comfrey root.
  • Herbal medicines containing this comfrey root preparation are available in semi-solid forms (such as creams or ointments) to be applied to the skin.
  • Comfrey root - Summary for the public
    Key facts
    - Latin name
    - Symphyti radix
    - English common name
    - Comfrey Root
    - Botanical name
    Symphytum officinale L.
    - Therapeutic area
    - Pain and inflammation
    - Status
    - F: Assessment finalised
    - Date added to the inventory
    - Date added to priority list
    - Outcome of European assessment
    - European Union herbal monograph

Inovia Vein Calls for Increased Awareness Around Deep Vein Thrombosis Risks During DVT Awareness Month

Retrieved on: 
Tuesday, March 5, 2024

With March being nationally recognized as Deep Vein Thrombosis (DVT) Awareness Month , Inovia Vein , a leading provider of world-class vein health services, is calling for enhanced education and awareness about this potentially life-threatening condition.

Key Points: 
  • With March being nationally recognized as Deep Vein Thrombosis (DVT) Awareness Month , Inovia Vein , a leading provider of world-class vein health services, is calling for enhanced education and awareness about this potentially life-threatening condition.
  • Inovia Vein’s vein health experts are stepping up to spread the word about the condition.
  • “That said, at Inovia Vein, we believe every month should be ‘DVT Awareness Month,’ and we are dedicated to educating the communities we serve and beyond about prevention and education.
  • Inovia Vein, the leading provider of vein health services, is dedicated to offering comprehensive and compassionate care to patients with venous disorders.

Dermavant to Present New ADORING Data Including Treatment of Patients with Skin of Color from Phase 3 Trials of VTAMA® (tapinarof) Cream, 1% in Adults and Children 2 Years of Age and Older with Atopic Dermatitis at the 2024 AAD Annual Meeting

Retrieved on: 
Friday, March 1, 2024

VTAMA cream is a novel, aryl hydrocarbon receptor agonist in development as a once-daily, cosmetically elegant, and steroid-free, topical cream for both acute treatment and long-term management of atopic dermatitis (AD).

Key Points: 
  • VTAMA cream is a novel, aryl hydrocarbon receptor agonist in development as a once-daily, cosmetically elegant, and steroid-free, topical cream for both acute treatment and long-term management of atopic dermatitis (AD).
  • VTAMA cream, 1% is currently approved for the topical treatment of plaque psoriasis in adults in the U.S. and is the same strength and formulation being studied in the ADORING Phase 3 development program for AD.
  • The following posters will be viewable onsite at the San Diego Convention Center.
  • Indication: VTAMA® (tapinarof) cream, 1% is an aryl hydrocarbon receptor agonist indicated for the topical treatment of plaque psoriasis in adults.

JUVÉDERM® VOLUMA® XC For Temple Hollows Receives U.S. FDA Approval

Retrieved on: 
Tuesday, March 5, 2024

IRVINE, Calif., March 5, 2024 /PRNewswire/ -- Today, Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced the U.S. FDA approval of JUVÉDERM® VOLUMA® XC for injection in the temple region to improve moderate to severe temple hollowing in adults over the age of 21.1 JUVÉDERM® VOLUMA® XC is the first and only hyaluronic acid (HA) dermal filler to receive U.S. FDA approval for the improvement of moderate to severe temple hollowing with results lasting up to 13 months with optimal treatment.*1

Key Points: 
  • *1
    "The approval of JUVÉDERM® VOLUMA® XC to treat temple hollows further demonstrates Allergan Aesthetics commitment to innovation and addressing patient needs," said Carrie Strom, President, Allergan Aesthetics and Senior Vice President, AbbVie.
  • "This is the first U.S. FDA approval of a hyaluronic acid dermal filler for use in the upper face and addresses a real unmet need for patients."
  • The safety of JUVÉDERM® VOLUMA® XC in patients with a history of excessive scarring or pigmentation disorders has not been studied.
  • To report a side effect with any product in the JUVÉDERM® Collection, please call the Allergan® Product Support Department at 1‑877‑345‑5372.

Chill. Stick. Go.: Compass Health Brands Delivers PAINCAKES® The Cold Pack That Sticks!® Bringing Disruption to The Cold Therapy Market

Retrieved on: 
Wednesday, February 28, 2024

QUINCY, Mass., Feb. 28, 2024 /PRNewswire-PRWeb/ -- Versatile and portable, PAINCAKES® is a cold pack that sticks and provides relief to sore muscles, aches, and pains.

Key Points: 
  • Versatile and portable, PAINCAKES® is a cold pack that sticks and provides relief to sore muscles, aches, and pains.
  • Each gel cold pack features a proprietary stick-and-stay technology that's been tested and proven to stick up to 100 times.
  • "We are very excited to introduce PAINCAKES® to consumers," says Tony West, Compass Health Brands' SVP of Retail.
  • This is the latest offering from Compass Health Brands, the same company that owns over 20 brands with thousands of products.

Enhancing Your Lips: Lip Flips vs. Lip Fillers

Retrieved on: 
Tuesday, February 27, 2024

When deciding between lip flips and lip filler, it's essential to consider your aesthetic goals, budget, and comfort level with each procedure.

Key Points: 
  • When deciding between lip flips and lip filler, it's essential to consider your aesthetic goals, budget, and comfort level with each procedure.
  • Let's dispel some of the most common misconceptions about lip flips and lip fillers.
  • Typically, the effects of lip fillers endure for around six months to one year, while lip flips generally last between 6 to 8 weeks.
  • Some people think that lip flips and lip fillers can cause long-term damage or change the structure of the lips.

Zynex Introduces New Products

Retrieved on: 
Tuesday, February 20, 2024

ENGLEWOOD, Colo., Feb. 20, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, introduced two new therapy products: the Zynex Pro Hybrid LSO and the Zynex DynaComp Cold Compression.

Key Points: 
  • ENGLEWOOD, Colo., Feb. 20, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, introduced two new therapy products: the Zynex Pro Hybrid LSO and the Zynex DynaComp Cold Compression.
  • The Zynex Pro Hybrid LSO is a versatile 3-in-1 spinal orthosis featuring a modular design that adapts seamlessly to individual patient needs.
  • The Zynex DynaComp Cold Compression is a cutting-edge device that combines cold therapy and compression to accelerate recovery anytime, anywhere.
  • "We are thrilled to introduce these new products to our customers," Thomas Sandgaard, Founder and CEO, comments.

FDA Approves First Cellular Therapy to Treat Patients with Unresectable or Metastatic Melanoma

Retrieved on: 
Friday, February 16, 2024

"Unresectable or metastatic melanoma is an aggressive form of cancer that can be fatal," said Peter Marks, M.D., Ph.D., director of the FDA's Center for Biologics Evaluation and Research (CBER).

Key Points: 
  • "Unresectable or metastatic melanoma is an aggressive form of cancer that can be fatal," said Peter Marks, M.D., Ph.D., director of the FDA's Center for Biologics Evaluation and Research (CBER).
  • Melanoma can spread to other parts of the body if not detected and treated early, resulting in metastatic disease.
  • Treatment for unresectable or metastatic melanoma may include immunotherapy using PD-1 inhibitors, which are antibodies targeting certain proteins in the body to help the immune system fight off cancer cells.
  • Those patients whose melanoma has progressed with these therapies have a high unmet medical need.

Is it broken? A strain or sprain? How to spot a serious injury now school and sport are back

Retrieved on: 
Friday, February 16, 2024

This can lead to two things: happy children and injuries.

Key Points: 
  • This can lead to two things: happy children and injuries.
  • Up to 50% of boys and 40% of girls will break a bone during childhood and adolescence.
  • But it is not just broken bones that can hamper your children’s Olympic dreams – or just disrupt their play.

Different doesn’t mean better or worse

  • Sprains, strains and fractures are all different types of injuries – and the type doesn’t necessarily indicate the severity.
  • Sprains are injuries to ligaments and joints.
  • So even a complete anterior cruciate ligament (ACL) rupture (when one of the ligaments of the knee is torn through) is technically a sprain.

Kids are at increased risk

  • ACL ruptures are also common in children, with the highest rise in ruptures among 5–14-year-old females in Australia, increasing by 10.4% from 1998 to 2018.
  • Some kids are not getting so much as a single physical recovery day per week and are training more than elite athletes while their bodies are still lanky, uncoordinated and developing.
  • In addition to muscle, tendon and bone injuries, children are also at risk of concussion and clear guidelines now exist to inform management of this condition.


Read more:
Concussion in sport: why making players sit out for 21 days afterwards is a good idea

With all that energy and commitment going into sport and play, it’s not surprising some kids hurt themselves. Here’s what to do next …

5 ways to assess the severity of an injury

  • Injuries with bigger changes in physical appearance will be much more severe.
  • If they are unable to bend a joint or they are “guarding” the area and refusing to move it, it is a sign of more severe injury.
  • Obviously, the more severe the injury the more likely your child will recoil with pain when being touched – or not let you anywhere near them.
  • If the injury does not seem to be changing or getting better within 24 hours it may be a more severe injury, even if the previous pointers do not suggest it is.


Read more:
Hot pack or cold pack: which one to reach for when you're injured or in pain

Now what? Top tips to manage injury


Do the basics well. No matter how severe an injury may be – the RICE protocol will be useful. RICE stands for rest, ice (with a pack or cold water if no ice is available), compression (with a bandage or fitted fabric) and elevation (position the body so the injury is above the level of the heart)
if your child has an obvious deformity of the bone, joint or muscle, seek medical attention as quickly as you can. The best thing to do is take them to an emergency department for assessment. They will likely need imaging (an X-ray or CT scan) to assess the bone and joint. Treatment should happen as soon as possible as injuries are often very painful and may need relocation or splinting
if your child is struggling to move the injured area, you are unable to touch the sore spot or they cannot tolerate taking weight on the injured area, a review with your GP or physiotherapist as soon as possible is your best course of action
if your child is not improving within 24 hours, but pain levels are not too high, an appointment with a GP or physiotherapist can still be a good idea. The injury may not be that severe, but if your child is needing to walk in an unusual way or not using their arm we want to get them back to normal as fast as possible
talk to your child and see what they want to do. If the problem is lingering and they are worried about getting back to sport or play, an assessment by someone qualified (usually the GP or physio) can be very reassuring.

Read more:
Is netball actually bad for knees and ankles? What does the research say?


Myles Murphy receives funding from the Raine Medical Research Foundation, Western Australian Department of Health, Perth Wildcats, Western Australia Police Force, Defence Science Centre of Western Australia.